114 related articles for article (PubMed ID: 6316872)
1. Delayed-type hypersensitivity in mice after infection with avirulent Semliki Forest virus. Brief report.
Kraaijeveld CA; Jansen J; Benaissa-Trouw B; Snippe H
Arch Virol; 1983; 78(1-2):115-8. PubMed ID: 6316872
[TBL] [Abstract][Full Text] [Related]
2. Delayed-type hypersensitivity against Semliki Forest virus in mice.
Kraaijeveld CA; Harmsen M; Khader Boutahar-Trouw B
Infect Immun; 1979 Feb; 23(2):219-23. PubMed ID: 422238
[TBL] [Abstract][Full Text] [Related]
3. Delayed type hypersensitivity against semliki forest virus in mice: local transfer of delayed type hypersensitivity with thioglycollate-induced peritoneal exudate cells.
Kraaijeveld CA; Benaissa-Trouw B; Harmsen M; Snippe H
Int Arch Allergy Appl Immunol; 1984; 73(4):342-6. PubMed ID: 6698625
[TBL] [Abstract][Full Text] [Related]
4. Dimethyl dioctadecyl ammoniumbromide as an adjuvant for delayed type hypersensitivity and cellular immunity against Semliki Forest virus in mice.
Kraaijeveld CA; Snippe H; Harmsen M; Khader Boutahar-Trouw B
Arch Virol; 1980; 65(3-4):211-7. PubMed ID: 7416968
[TBL] [Abstract][Full Text] [Related]
5. The role of complement in monoclonal antibody-mediated protection against virulent Semliki Forest virus.
Boere WA; Benaissa-Trouw BJ; Harmsen T; Erich T; Kraaijeveld CA; Snippe H
Immunology; 1986 Aug; 58(4):553-9. PubMed ID: 3015781
[TBL] [Abstract][Full Text] [Related]
6. Aspects of monoclonal antibody-mediated protection of mice against infection with virulent Semliki Forest virus.
Boere WA; Kraaijeveld CA; Snippe H
Antiviral Res; 1985; Suppl 1():149-53. PubMed ID: 2417548
[No Abstract] [Full Text] [Related]
7. Properties of host and virus which influence defective interfering virus mediated-protection of mice against Semliki Forest virus lethal encephalitis. Brief report.
Barrett AD; Dimmock NJ
Arch Virol; 1984; 81(1-2):185-8. PubMed ID: 6331348
[TBL] [Abstract][Full Text] [Related]
8. Modulation of a systemic Semliki Forest virus infection in mice by defective interfering virus.
Barrett AD; Dimmock NJ
J Gen Virol; 1984 Oct; 65 ( Pt 10)():1827-31. PubMed ID: 6092526
[TBL] [Abstract][Full Text] [Related]
9. The effect of mouse strain on the pathogenesis of the encephalitis and demyelination induced by avirulent Semliki Forest virus infections.
Suckling AJ; Jagelman S; Illavia SJ; Webb HE
Br J Exp Pathol; 1980 Jun; 61(3):281-4. PubMed ID: 6252935
[TBL] [Abstract][Full Text] [Related]
10. Semliki Forest virus (A7[74]) infection of adult mice induces an immune-mediated demyelinating encephalomyelitis.
Fazakerley JK; Khalili-Shirazi A; Webb HE
Ann N Y Acad Sci; 1988; 540():672-3. PubMed ID: 2849913
[No Abstract] [Full Text] [Related]
11. Modulation of adjuvant-enhanced delayed-type hypersensitivity by the interferon inducers poly I:C and Newcastle disease virus.
Kraaijeveld CA; Kamphuis W; Benaissa-Trouw BJ; Harmsen M; Snippe H
Int Arch Allergy Appl Immunol; 1986; 79(1):86-9. PubMed ID: 2416698
[TBL] [Abstract][Full Text] [Related]
12. Semliki Forest virus-induced, immune-mediated demyelination: adoptive transfer studies and viral persistence in nude mice.
Fazakerley JK; Webb HE
J Gen Virol; 1987 Feb; 68 ( Pt 2)():377-85. PubMed ID: 3029281
[TBL] [Abstract][Full Text] [Related]
13. Immunoglobulin synthesis in nude (nu/nu), nu/+ and reconstituted nu/nu mice infected with a demyelinating strain of Semliki Forest virus.
Suckling AJ; Jagelman S; Webb HE
Clin Exp Immunol; 1982 Feb; 47(2):283-8. PubMed ID: 6280913
[TBL] [Abstract][Full Text] [Related]
14. Modulation of Semliki Forest virus-induced infection of mice by defective-interfering virus.
Barrett AD; Dimmock NJ
J Infect Dis; 1984 Jul; 150(1):98-104. PubMed ID: 6086774
[TBL] [Abstract][Full Text] [Related]
15. Blocking by anti-idiotypic antibodies of monoclonal antibody-mediated protection against lethal Semliki Forest virus in mice.
Oosterlaken TA; Harmsen M; Kraaijeveld CA; Snippe H
Scand J Immunol; 1990 Feb; 31(2):159-65. PubMed ID: 2155475
[TBL] [Abstract][Full Text] [Related]
16. The pathogenicity of the M9 mutant of Semliki Forest virus in immune-compromised mice.
Gates MC; Sheahan BJ; Atkins GJ
J Gen Virol; 1984 Jan; 65 ( Pt 1)():73-80. PubMed ID: 6319575
[TBL] [Abstract][Full Text] [Related]
17. Macrophages bind directly to Semliki Forest virus-infected cells and mediate antibody-dependent cell-mediated cytotoxicity.
Macfarlan RI; White DO
Aust J Exp Biol Med Sci; 1984 Apr; 62 ( Pt 2)():193-7. PubMed ID: 6087780
[TBL] [Abstract][Full Text] [Related]
18. Immunological reaction of the demyelinating Semliki Forest virus with immune serum to glycolipids and its possible importance to central nervous system viral auto-immune disease.
Webb HE; Mehta S; Gregson NA; Leibowitz S
Neuropathol Appl Neurobiol; 1984; 10(2):77-84. PubMed ID: 6328340
[TBL] [Abstract][Full Text] [Related]
19. Humoral and cell-mediated immune mechanisms in the production of pathology in avirulent Semliki Forest virus encephalitis.
Berger ML
Infect Immun; 1980 Oct; 30(1):244-53. PubMed ID: 6254882
[TBL] [Abstract][Full Text] [Related]
20. Protection of mice from Semliki Forest virus infection by lymphocytes treated with low levels of interferon.
Stanton GJ; Lloyd RE; Sarzotti M; Blalock JE
Mol Biother; 1989; 1(6):305-10. PubMed ID: 2558683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
